This website uses cookies to ensure you get the best experience on our website. Privacy Policy

Contact
Login
Sign Up Free

Transformative Evidence
- mCRPC
  - CARD Trial
  - VISION Trial
- mHSPC
  - ARASENS Trial
- nmCRPC
  - ARAMIS Trial
- PSMA PET Imaging
  - CONDOR Trial
  - OSPREY Trial
- Bladder Cancer
  - Bladder Cancer Detection
- Advanced Bladder Cancer
  - JAVELIN Bladder 100 Trial
Centers of Excellence
- Urologic Oncology
  - Left Group
    - Bladder Cancer
      - Bladder Cancer
        Ashish Kamat, MD
      - Advanced Bladder Cancer
        Petros Grivas, MD
    - Kidney Cancer
      - Advanced Kidney Cancer
        Pedro Barata, MD, MSc
      - Kidney Cancer Today
        Sumanta (Monty) Kumar Pal, MD
        Jaime Landman, MD
  - Prostate Cancer
  - Upper Tract Urothelial Carcinoma
    - Upper Tract Urothelial Carcinoma
      Sam S. Chang, MD, MBA
  - TESTICULAR, PENILE & RARE GU MALIGNANCIES
    - Testicular, Penile, and Rare GU Malignancies
- Pelvic Health & Reconstruction
Videos
- Exclusives
- Urologic Oncology
Clinical Trials
- From the Editor
  - Search Clinical Trials
- Transformative Trials
Articles
- Urology (benign and malignant)
- Pelvic Health
  - Pelvic Health & Reconstruction
Conference Coverage
- Recent Conferences
  - BCANTT 2022
  - EAU 2022
- See All
  - See All Conference Coverage
PCF

UroToday Home
Newsletter Archive

Newsletters

Prostate Cancer DailySent on 16 August 2022 Receive via e-mail

Uroalerts Men's Health WeeklySent on 15 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 15 August 2022 Receive via e-mail

Endourology / Stone Disease WeeklySent on 15 August 2022 Receive via e-mail

Treatment of Biochemical Recurrent Prostate Cancer Sent on 15 August 2022 Receive via e-mail

Kidney Cancer WeeklySent on 15 August 2022 Receive via e-mail

Bladder Cancer WeeklySent on 15 August 2022 Receive via e-mail

Prostate Cancer DailySent on 15 August 2022 Receive via e-mail

Lower Urinary Tract Symptoms WeeklySent on 15 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 14 August 2022 Receive via e-mail

Imaging Considerations When Treating Nonmetastatic Castrate-Resistant Prostate CancerSent on 14 August 2022 Receive via e-mail

Prostate Cancer DailySent on 12 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 11 August 2022 Receive via e-mail

Managing Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer and DNA Repair Gene Defects Sent on 11 August 2022 Receive via e-mail

Prostate Cancer DailySent on 11 August 2022 Receive via e-mail

UroAlert - GU Oncology WeeklySent on 11 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 10 August 2022 Receive via e-mail

How Genomic Testing Impacted Treatment Decision-Making Among a Predominantly African American PopulationSent on 10 August 2022 Receive via e-mail

Prostate Cancer DailySent on 10 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 09 August 2022 Receive via e-mail

BCAN Think Tank 2022 Highlights - Collaborating to Move Research Forward in Bladder CancerSent on 09 August 2022 Receive via e-mail

UroAlerts - Prostate Cancer WeeklySent on 09 August 2022 Receive via e-mail

Prostate Cancer DailySent on 09 August 2022 Receive via e-mail

Uroalerts Men's Health WeeklySent on 08 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 08 August 2022 Receive via e-mail

Endourology / Stone Disease WeeklySent on 08 August 2022 Receive via e-mail

Urologist Perspective on the Approval of Darolutamide for Metastatic Hormone-Sensitive Prostate CancerSent on 08 August 2022 Receive via e-mail

Kidney Cancer WeeklySent on 08 August 2022 Receive via e-mail

Bladder Cancer WeeklySent on 08 August 2022 Receive via e-mail

Prostate Cancer DailySent on 08 August 2022 Receive via e-mail

Lower Urinary Tract Symptoms WeeklySent on 08 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 07 August 2022 Receive via e-mail

Transforming Bladder Cancer Care - Highlights from the 2022 Bladder Cancer Think Tank MeetingSent on 05 August 2022 Receive via e-mail

Breaking News: Darolutamide Approved for Metastatic Hormone-Sensitive Prostate CancerSent on 05 August 2022 Receive via e-mail

Prostate Cancer DailySent on 05 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 04 August 2022 Receive via e-mail

NCCN Guidelines on the Management of Localized Prostate Cancer and More in Expert-Led Journal Clubs Sent on 04 August 2022 Receive via e-mail

Prostate Cancer DailySent on 04 August 2022 Receive via e-mail

UroAlert - GU Oncology WeeklySent on 04 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 03 August 2022 Receive via e-mail

PSMA PET for Primary Staging Impacting the Management of Prostate CancerSent on 03 August 2022 Receive via e-mail

Prostate Cancer DailySent on 03 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 02 August 2022 Receive via e-mail

Incorporating Molecular Testing and Clinical Markers into Clinical Practice for Prostate CancerSent on 02 August 2022 Receive via e-mail

UroAlerts - Prostate Cancer WeeklySent on 02 August 2022 Receive via e-mail

Prostate Cancer DailySent on 02 August 2022 Receive via e-mail

Uroalerts Men's Health WeeklySent on 01 August 2022 Receive via e-mail

UroAlert - GU Oncology DailySent on 01 August 2022 Receive via e-mail

Endourology / Stone Disease WeeklySent on 01 August 2022 Receive via e-mail

Clinical Trials in Progress - Focus on Advanced Prostate Cancer Sent on 01 August 2022 Receive via e-mail

Page of 193

Display #
Results 1 - 50 out of 9632

Send the selected Newsletters to...

Name
E-mail

email news signup

About UroToday
Journals
Calendar
Editorial and Advertising Guidelines
Editors and Contributors
FAQs
Privacy Policy
Terms of Use

Follow UroToday

COPYRIGHT © 2002 - 2022 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

Email

Password

Forgot Password?
Sign Up Free